Literature DB >> 29947879

Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? No.

Jean-Louis Vincent1, John J Marini2, Antonio Pesenti3,4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29947879     DOI： 10.1007/s00134-018-5220-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  9 in total

1.  Indications for blood transfusions: too complex to base on a single number?

Authors:  Jean-Louis Vincent
Journal:  Ann Intern Med       Date:  2012-07-03       Impact factor: 25.391

2.  Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.

Authors:  Theodore J Iwashyna; James F Burke; Jeremy B Sussman; Hallie C Prescott; Rodney A Hayward; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2015-11-01       Impact factor: 21.405

3.  High versus low blood-pressure target in patients with septic shock.

Authors:  Pierre Asfar; Ferhat Meziani; Jean-François Hamel; Fabien Grelon; Bruno Megarbane; Nadia Anguel; Jean-Paul Mira; Pierre-François Dequin; Soizic Gergaud; Nicolas Weiss; François Legay; Yves Le Tulzo; Marie Conrad; René Robert; Frédéric Gonzalez; Christophe Guitton; Fabienne Tamion; Jean-Marie Tonnelier; Pierre Guezennec; Thierry Van Der Linden; Antoine Vieillard-Baron; Eric Mariotte; Gaël Pradel; Olivier Lesieur; Jean-Damien Ricard; Fabien Hervé; Damien du Cheyron; Claude Guerin; Alain Mercat; Jean-Louis Teboul; Peter Radermacher
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

4.  Early goal-directed therapy: do we have a definitive answer?

Authors:  Daniel De Backer; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2016-03-07       Impact factor: 17.440

5.  Do we need randomized clinical trials in extracorporeal respiratory support? We are not sure.

Authors:  Jean-Louis Vincent; Laurent J Brochard
Journal:  Intensive Care Med       Date:  2017-09-25       Impact factor: 17.440

6.  Time to Rethink the Approach to Treating Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; John J Marini; Michael Quintel
Journal:  JAMA       Date:  2018-02-20       Impact factor: 56.272

7.  Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.

Authors:  Djillali Annane; Alain Renault; Christian Brun-Buisson; Bruno Megarbane; Jean-Pierre Quenot; Shidasp Siami; Alain Cariou; Xavier Forceville; Carole Schwebel; Claude Martin; Jean-François Timsit; Benoît Misset; Mohamed Ali Benali; Gwenhael Colin; Bertrand Souweine; Karim Asehnoune; Emmanuelle Mercier; Loïc Chimot; Claire Charpentier; Bruno François; Thierry Boulain; Franck Petitpas; Jean-Michel Constantin; Gilles Dhonneur; François Baudin; Alain Combes; Julien Bohé; Jean-François Loriferne; Roland Amathieu; Fabrice Cook; Michel Slama; Olivier Leroy; Gilles Capellier; Auguste Dargent; Tarik Hissem; Virginie Maxime; Eric Bellissant
Journal:  N Engl J Med       Date:  2018-03-01       Impact factor: 91.245

8.  Oxygenation response to positive end-expiratory pressure predicts mortality in acute respiratory distress syndrome. A secondary analysis of the LOVS and ExPress trials.

Authors:  Ewan C Goligher; Brian P Kavanagh; Gordon D Rubenfeld; Neill K J Adhikari; Ruxandra Pinto; Eddy Fan; Laurent J Brochard; John T Granton; Alain Mercat; Jean-Christophe Marie Richard; Jean-Marie Chretien; Graham L Jones; Deborah J Cook; Thomas E Stewart; Arthur S Slutsky; Maureen O Meade; Niall D Ferguson
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

9.  Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.

Authors:  Balasubramanian Venkatesh; Simon Finfer; Jeremy Cohen; Dorrilyn Rajbhandari; Yaseen Arabi; Rinaldo Bellomo; Laurent Billot; Maryam Correa; Parisa Glass; Meg Harward; Christopher Joyce; Qiang Li; Colin McArthur; Anders Perner; Andrew Rhodes; Kelly Thompson; Steve Webb; John Myburgh
Journal:  N Engl J Med       Date:  2018-01-19       Impact factor: 91.245
  9 in total
  3 in total

Review 1.  Venous and arterial thrombosis in COVID-19: An updated narrative review.

Authors:  Zainab Al Duhailib; Simon Oczkowski; Kamil Polok; Jakub Fronczek; Wojciech Szczeklik; Joshua Piticaru; Manoj J Mammen; Fayez Alshamsi; John Eikelboom; Emilie Belley-Cote; Waleed Alhazzani
Journal:  J Infect Public Health       Date:  2022-05-14       Impact factor: 7.537

2.  Precision medicine for COVID-19: a call for better clinical trials.

Authors:  Gentle Sunder Shrestha; Hem Raj Paneru; Jean-Louis Vincent
Journal:  Crit Care       Date:  2020-06-02       Impact factor: 9.097

3.  The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption.

Authors:  Carola Giménez-Esparza; Cristina Portillo-Requena; Francisco Colomina-Climent; José Manuel Allegue-Gallego; María Galindo-Martínez; Cristina Mollà-Jiménez; José Luis Antón-Pascual; Enrique Mármol-Peis; Cristina Dólera-Moreno; Manuel Rodríguez-Serra; José Luis Martín-Ruíz; Pablo Juan Fernández-Arroyo; Eugenia María Blasco-Císcar; José Cánovas-Robles; Enrique González-Hernández; Fernando Sánchez-Morán; Manuel Solera-Suárez; Jesús Torres-Tortajada; Antonio Palazón-Bru; Vicente F Gil-Guillen
Journal:  BMJ Open       Date:  2019-12-03       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.